STAT+: How to tell if Biden drove a hard bargain on drug prices
WASHINGTON — The deadline for announcing how much Medicare lowered drug prices in the first…
Category: Medicare negotiation
STAT+: Drugmakers are losing crucial friends on Capitol Hill
WASHINGTON — Sen. Bob Menendez is the poster child for a pharmaceutical industry ally. He…
STAT+: Medicare expected to negotiate obesity drug prices soon, new analysis predicts
WASHINGTON — Medicare will likely choose the obesity drug semaglutide for price negotiation “within the…
In his State of the Union, Biden takes clear aim at ‘Big Pharma’
WASHINGTON — Often, a president’s State of the Union address is a staid affair, with…
STAT+: Pharma giants, government spar in court over Medicare drug price negotiation
TRENTON, N.J. — Pharma industry giants including Bristol Myers Squibb, Johnson and Johnson, Novartis, and…
Biden to propose expanding Medicare drug price negotiation in State of the Union
WASHINGTON — President Biden wants to more than double the size of Medicare’s new drug…
.jpg)
STAT+: Federal judge rules against AstraZeneca in lawsuit challenging Medicare drug price negotiation
WASHINGTON — A federal judge in Delaware on Friday ruled against AstraZeneca in a case…
House looks to weaken Medicare negotiation
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
STAT+: Judge tosses PhRMA lawsuit over Medicare power to negotiate drug prices
WASHINGTON — A federal district judge on Monday granted the Biden administration’s request to dismiss…
In a showy hearing, Bernie Sanders gets few answers about lower drug prices
WASHINGTON — Call it Sen. Bernie Sanders’ prescription drug pricing theater. The hearing, featuring Merck…
STAT+: Merck, Johnson & Johnson CEOs agree to testify in Congress on high drug prices, avoiding Bernie Sanders’ subpoena
WASHINGTON — Merck CEO Robert Davis and Johnson and Johnson CEO Joaquin Duato have agreed…
Merck CEO refused to testify in Senate because he’s not an expert in drug pricing, Bernie Sanders says
WASHINGTON — Sen. Bernie Sanders on Thursday jabbed the CEO of Merck for telling congressional…
STAT+: Pharma’s attack on Medicare drug price negotiation might benefit Biden
WASHINGTON — Pharmaceutical companies are doing anything they can to stop President Biden’s Medicare program…
Will a government shutdown stall Medicare drug price negotiations?
You’re reading the web edition of D.C. Diagnosis. Sign up here to receive this newsletter in your…
STAT+: Hearing on Medicare drug price negotiation gets unusually heated
WASHINGTON — Republicans and Democrats fought it out over Medicare drug price negotiation Wednesday at…
Opinion: How the drug price negotiation program could affect Medicare Part D beneficiaries
After the recent announcement of the first 10 drugs selected for Medicare price negotiation, much…
STAT+: Why the drug industry’s opaque warnings on price negotiations fall short
Ever since Medicare was given power to negotiate prices for certain medicines, the pharmaceutical industry…
Opinion: What does ‘bona fide competition’ actually mean in the biologics market?
On Aug. 29, Medicare released its highly anticipated list of 10 therapies for which it…
STAT+: Astellas withdraws lawsuit after evading Medicare drug price negotiations
WASHINGTON — Astellas was so sure that one of its drugs was going to be…
STAT+: Congress’s PBM reforms won’t end America’s drug pricing woes. Here’s what they would do
WASHINGTON — Lawmakers in Congress generally agree that there’s something very broken with the way America…
STAT+: Johnson & Johnson sues to stop Medicare negotiation
WASHINGTON — Pharmaceutical giant Johnson & Johnson on Tuesday became the third drugmaker to sue the…
STAT+: Medicare official insists drug price negotiation will consider value of drugs
WASHINGTON — When Medicare starts negotiating drug prices, it will take into account how important…
STAT+: Senate still hasn’t made hard decisions on lowering insulin costs
WASHINGTON — Senate Democrats are trying to cap insulin costs for every American, but they…
STAT+: PhRMA execs paint grim picture of industry under Medicare drug price negotiation
WASHINGTON — Executives for the brand drug industry’s biggest lobbying group painted a grim picture…
STAT+: Medicare advisers endorse reforms to lower drug spending
In the latest move to address prescription drug pricing, the Medicare Payment Advisory Commission unanimously…
STAT+: Could a fight over cost-effectiveness upend Medicare drug price negotiation before it’s begun?
WASHINGTON — As Medicare drug price negotiation looms, congressional Republicans are scrambling to push through…
STAT+: Medicare explains how it will choose drugs for negotiation
WASHINGTON — Medicare laid out Thursday in the greatest detail yet how it will choose…
STAT+: Biden administration to fine manufacturers of 27 medicines for price hikes
WASHINGTON — The Biden administration will fine drugmakers who hiked prices faster than the rate…
STAT+: PhRMA chief dings health insurers over drug prices at their own conference
WASHINGTON — The head of the brand drug lobby used an in-person health insurance industry…
STAT+: Medicare will take R&D costs, effectiveness into account when it negotiates drug prices. But studies show that doesn’t affect prices
By law, Medicare will have to take a medication’s efficacy and its research and development…
STAT+: Biden makes drug pricing a central part of his deficit reduction plans
WASHINGTON – President Biden made lowering drug prices a key part of his budget with…
STAT+: Medicare chief on the new drug price negotiation program’s operations, hiring, and timelines
WASHINGTON — Medicare officials are still hammering out the technical specifics of how the massive…
Biden proposes expanding Medicare drug negotiation program
WASHINGTON — The Biden administration will propose expanding Democrats’ new drug pricing law by allowing…
STAT+: HHS will seek more input on its new Medicare drug price negotiations
WASHINGTON — The Department of Health and Human Services is gearing up to start releasing…
STAT+: PhRMA, once invincible in Washington, has lost its edge
WASHINGTON — PhRMA has a reputation in Washington for might, for money, for scorched-earth tactics,…
STAT+: Despite its threats, PhRMA is still supporting Democrats who voted for Medicare negotiation
Drugmakers’ powerhouse lobby did not exactly make good on its early August threat to hold…
STAT+: Drugmakers will be penalized if they hike prices on patients in private insurance market
WASHINGTON — Democrats’ drug pricing law will still penalize drugmakers if they hike prices on…
STAT+: Medicare tasks a senior adviser with staffing its new drug pricing division
WASHINGTON — Medicare has tasked a senior adviser at the agency with assembling a small…
STAT+: Medicare lays out the bureaucracy it will need to negotiate drug prices
WASHINGTON — New documents obtained by STAT outline how Medicare is planning to build out…
Opinion: Launch prices: tackling the next drug pricing challenge
The passage of the Inflation Reduction Act brings a new era to drug pricing in…
STAT+: Pharma’s likely to sue over Medicare negotiation. Here are the arguments they might use
WASHINGTON — Democrats finally achieved a win over the pharmaceutical industry this month when they…
STAT+: Unpacking the drug pricing policies that Congress just approved
WASHINGTON — Medicare coverage for prescription drugs will look very different when President Biden signs…
In a momentous vote for Pelosi, House sends drug pricing reforms to President Biden’s desk
WASHINGTON — Fifteen years later, House Speaker Nancy Pelosi is fulfilling one of her first campaign…
Here’s who Democrats’ drug pricing bill will actually help
WASHINGTON — Millions of patients in the Medicare program could eventually see lower prescription drug costs…
STAT+: The Senate’s drug pricing bill is an inevitable solution. It will still have plenty of unintended consequences
There’s really no ignoring the inexorable math that led the Senate to approve a plan…
In a massive victory for Democrats, Medicare is poised to negotiate drug prices
WASHINGTON — President Biden is on the verge of his own crowning health care achievement…
Democrats dramatically narrow their ambitions for lowering insulin costs
WASHINGTON — Democrats’ high hopes to lower insulin costs for patients with insurance got downsized on…
Democrats will have to limit their drug pricing reforms to Medicare to comply with Senate rules
WASHINGTON — Democrats will likely have to axe two provisions from their drug pricing plan…
The view on drug pricing from Wall Street, a pharma-friendly Dem holds firm, and what’s next for a big telehealth bill
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
STAT+: ‘What can we do?’: Pharma lobbyists face their biggest test in a decade, as Democrats barrel toward a vote on drug pricing
WASHINGTON — The pharmaceutical industry, notorious for its deep pockets and aggressive lobbying tactics, has a…